Sponge is an immemorial species appeared on the earth in the early Cambrian period, 1 it outspread very widely in the Jurassic and the Cretaceous period from marine to freshwater. 2 Many novel and biologically active compounds have frequently been isolated from the marine sponges these years, while research papers about freshwater sponges were lesser. Freshwater sponge Spongilla lacustris has been used as a traditional Chinese medicine 3, 4 for near upon 500 years in China for reinforcing the kidney and supporting yang (aphrodisiac), nevertheless the pharmacy research of this species is fewer. 5 To make clear the chemical components of Spongilla lacustris further, the cosmopolitan species 6 were selected as our material and leading to the isolation of one new spongilipid, tetracosan-1-ol-1-O-β-D-gluco-pyranoside (1), together with ten known compounds, 1-palmitoyl-3-β-D-galactosylsn-glycerol (2), 7 cholesterol (3), 5 5α-cholest-7-ene-3β, 6α-diol (4), [8] [9] [10] cholest-5-ene-3β, 7β-diol (5), 11 cholest-5-ene-3β, 7α-diol (6), 11 (22E)-cholest-5, 22-diene-3β, 7α-diol (7), 11 24ξ-ethylcholest-5-ene-3β, 7α-diol (8), 12 cholest-7-ene-3β, 5α, 6β-triol (9), 13 (24S)-24-ethyl-cholest-7, 22-ene-3β, 5α, 6β-triol (10) 13 and (24S)-24-ethyl-cholest-7-ene-3β, 5α, 6β-triol (11). [13] [14] [15] The cytotoxic activity of compound 1 against two human tumor cell lines (A549 and HL-60) was also assessed and showed no activities at concentrations up to 10 -4 mol/L. EIMS spectrum of acetifying of hydrolysate of 1. The ion peak (m/z 397 [1 -Glc + AcO] + ) in the FABMS spectrum after hydrolyzing and acetifying of 1 proved it further. The crosspeak of atom at δ 4.85 (H-1') with carbon at δ 69.9 (C-1) in the HMBC spectrum of 1 (Fig. 2) indicated that the β-D-glucopyranose was linked to C-1 of the tetracosanol group. Compound 1 with four hydroxyls was further confirmed by ion peak (m/z 707 [1 + 4AcO -4H + Na] + ) in ESIMS after its acetification. Thus, compound 1 was determined as tetra-
The ten known compounds were identified on the basis of spectroscopic analysis and comparing spectra data with literature or Rf values with authentic samples.
Experimental
General procedures. Melting points were measured on a XRC-1 micro-melting point apparatus and are uncorrected. MS spectra were obtained on a VG Auto Spec-3000 mass spectrometer. 1D and 2D NMR spectra were recorded on Bruker AM-400 MHz and DRX-500 spectrometers, with chemical shifts (δ) in ppm relative to TMS as internal standard and coupling constants in hertz (Hz). IR spectra were measured with a Bio-Rad FTS-135 IR spectrometer with KBr pellets. UV spectra were measured on a Hitachi UV-3210 spectrophotometer. Silica gel (200-300 mesh) for column chromatography and preparative thin-layer chromatography were the products of the Qindao Marine Chemical Ltd., Qingdao, P. R. China. Sephadex LH-20 for chromatography was purchased from Amersham Biosciences. Reversed-phase chromatography was with RP-18 (LiChroprep, 40-63 µm, Merck, Darmstadt, Germany).
Animal material. The dried green sponge Spongilla lacustris (4.5 kg) was collected from Tenchong, Yunnan Province, P. R. China, in November 2004 and identified by Prof. Li-zhen Wang, Yunnan University, Kunming, Yunnan, P. R. China. A voucher specimen (Zhai-1) is deposited at the Kunming Institute of Botany, Chinese Academy of Science, Kunming, Yunnan, P. R. China.
Extraction and isolation. The air-dried sponge (4.0 kg) was powdered and extracted three times with 80 % ethanol aq. (30 L × 3) at room temperature for 24 hours each time and filtered. The filtrate was evaporated under reduced pressure to give a residue, which was suspended in water and partitioned successively with petroleum ether, EtOAc and n-BuOH. The EtOAc-soluble fraction was concentrated to give a deep green gum (180.0 g) and subjected to column chromatography (CC) (silica gel, CHCl3-CH3OH, 10 : 0 → 8 : 2) to give 5 fractions A-E. Fraction B (10 g) was further purified by CC (silica gel, CHCl3-CH3OH, 92 : 8) and CC (Sephadex LH-20, CHCl3-CH3OH, 7 : 3) to afford compound 3 (1.0 g) and 4 (15 mg). Fraction C was treated same as fraction B to produce compound 5 (8 mg) and a white crystal (40 mg), the crystal was further separate by semi preparative HPLC (Agilent ODS-C18, CH3OH-H2O, 91 : 9) to produce compound 6 (5 mg), 7 (6 mg) and 8 (4 mg). Fraction D was treated same as fraction C and afford compound 9 (4 mg), 10 (5 mg) and 11 (4 mg). The n-BuOH soluble fraction was concentrated to give a deep brown gum (100.0 g), part of which (95.0 g) was subjected to CC (silica gel, CHCl 3 -CH 3 OH, 9 : 1 → 7 : 3) to give eight fractions (I-VIII). Fraction III (9. -(calcd. for C30H59O6, 515.4311). Acetylate and hydrolysis. The sample (compound 1, 2 mg) was dissolved in MeOH/H2O (8 : 2) in a 50 mL rockered flask and 5 drops of HCl (36%) were added. After refluxed at 80 ºC for 4 hours, the hydrolysate was allowed to cool and separated successfully between petroleum ether and MeOH/H2O (8 : 2). The petroleum ether layer was concentrated and sent for EIMS and GC-MS. The residual petroleum ether layer dissolved in Ac2O/pyridine (6 : 1) in a sealed micro-flask and reacted at 60 ºC for 4 hours, and then the acetic reactant was subjected to positive FABMS analysis.
The sample (compound 1, 1 mg) was dissolved in Ac2O/ pyridine (6:1) in a sealed micro-flask and reacting at 60 ºC for 4 hours, then the reactant was subjected to positive ESIMS analysis.
Cytotoxic assay. Compound 1 was tested for its cytotoxic effects against human lung carcinoma A549 and human leukemia HL-60 cell lines using the sulforhodamine B (SRB) Notes assay and the methyl-thiazol-tetrozolium (MTT) assay, respectively.
